Neurochemistry, toxic/metabolic Flashcards
Ionotropic vs metabotropic receptors
Ionotropic receptors are ion channels gated by the binding of a neurotransmitter. Example: GABA-A receptor is a chloride channel.
Metabotropic receptors activate intracellular signaling pathways via G-proteins. Example: GABA-B receptor is G-protein coupled
Sodium
Low inside, high outside, causes depolarizing currents
Potassium
High inside, low outside, inhibitory/stabilizing currents
** Critical role in setting resting membrane potential due to high resting conductance in excitable cells
Chloride
May be high or low depending on the cell, so could be either excitatory or inhibitory
(GABA-A receptor uses chloride currents, mostly inhibitory in adult brain)
Calcium
Very low (nanomolar range) inside, high outside (10 mM) Excitatory currents but, more importantly raising calcium can trigger intracellular signals for neurotransmitter release, LTP, and other events
Voltage gated sodium channels
Genes for the major subunits are called “SCN”
Proteins are called “Nav”
Inhibited by tetrodotoxin, local anesthetics (lidocaine)
Gate in response to depolarizationallow rapid sodium influxmore depolarization
Very useful for propagating action potentials
Activate in response to depolarization but also inactivate (action potentials terminate)
Voltage gated calcium channels
Voltage-gated calcium channels (VGCC) can open in response to depolarization like Nav channels
Can rapidly raise calcium levels inside the cell – transforming the electrical signal to a chemical signal
In the presynaptic terminal, VGCCs trigger neurotransmitter release
In cardiac muscle, calcium influx triggers contraction
skeletal muscle is different – relies on releasing intracellular stores of calcium using a protein complex that includes the ryanodine receptor and the DHPR (which is like a modified calcium channel)
Voltage gated potassium channels
Relatively high K conductance at rest keeps most cells resting membrane potential near the potassium reversal potential (-70mV to -90mV or so) – neurons, cardiac myocytes, skeletal muscle, etc.
VGKCs (or “Kv” channels) open in response to depolarization
They are an inhibitory influence, help terminate action potentials
Think of them as opposing Nav channels – the main brake to counter the sodium channel acceleration
There is an incredible diversity of families of potassium channels
VGKCC antibodies
VGKC antibodies do not actually target potassium channel subunits per se but rather associated proteins LGI1 or Caspr2
Cl channels
Chloride may be high or low inside cells by using one of two transporters:
– KCC2 (K-Cl cotransporter) keeps chloride low, making chloride current inhibitory
– NKCC (Na-K-Cl cotransporter, 2 forms exists) keeps chloride high, making chloride currents excitatory
Big chloride channels: GABA-A, glycine receptor, CLC1 (skeletal muscle)
GABA metabolism
GAD is the enzymes that makes GABA from glutamate
• GAD67 form of the enzymes is ubiquitous
• GAD65 isoform is concentrated in presynaptic terminals of GABA-ergic neurons, and rapidly replenishes synaptic vesicles with GABA
GABA-A receptors
Pentameric choride channels activated by GABA – incredible subunit diversity: ionotropic receptors
Primary fast inhibitory receptor in the brain
Barbiturates prolong channel opening
Benzodiazepines increase frequency of channel opening
Clobazam (Onfi) acts on the benzodiazepine site
Both have a nasty withdrawal profile with risk of seizures
Flumazenil is a benzodiazepine antagonist (rapid treatment of benzodiazepine overdose)
Anti-GABA-A receptor encephalitis is a rare autoimmune brain disease with severe seizures/status
Glycine
Very similar to GABA-A receptors – chloride channels
Primary rapid inhibitory signaling system in the spinal cord
Antagonist strychnine produces painful muscle contractions, spasms, exaggerate startle – due to spinal hyperexcitability
Glycine mutations associate with human startle disease
Glycine antibodies associate with PERM (progressive encephalomyelitis with rigidity and myoclonus) – like stiff person syndrome with startle and encephalitis
GABA-B receptors
Metabotropic receptors activited by GABA
Shut down presynaptic release and indirectly trigger post-synaptic inhibitory potassium currents via GIRK channels
Baclofen is an agonist, widely used for spasticity. Has nasty withdrawal syndrome
Phaclofen is an antagonist
Anti-GABA-B encephalitis is an autoimmune encephalitis with severe seizures. Antibodies disrupt GABA-B receptor function.
Glutamate receptors
Glutamate is the major excitatory neurotransmitter in the CNS
Several types of ionotropic receptor (AMPA receptor, Kainate receptor, NMDA receptor) accomplish routine rapid transmission
A family of metabotropic receptors (mGluR1, etc.) modulate neuronal function in complex ways
AMPA receptor
Ionotropic glutamate receptors with significant sodium permeability (create strong depolarization)
Useful for routine fast excitatory signals in the CNS
Cannot by itself trigger long-term potentiation due to low calcium permeability
Creates an electrical signal but not a chemical signal
Kainate receptors are similar to AMPA receptors
NMDA receptor
The NMDA receptor integrates a presynaptic signal (glutamate release) with post-synaptic
depolarization because it requires both to gate. NMDARs open only when there is glutamate release at its synapse from the pre-synaptic neuron AND the post- synaptic neuron is strongly excited.
NMDA receptors are ion channels (ionotropic) that have significant calcium permeability (Na/K/Ca), raising post-synaptic calcium levels to trigger LTP.
Long-term potentiation (LTP) triggered by calcium will strengthen that synapse.
Anti-NMDA encephalitis
Characteristic autoimmune brain disease with psychosis, memory impairment, dysautonomia, catatonia, seizures, coma. Antibodies disrupt NMDAR function
NMDA and drugs of abuse, medications
Phencyclidine (PCP, “Angel dust”) – hallucinogenic drug of abuse, an NMDA receptor antagonist
Ketamine – anesthetic, also an NMDA receptor antagonist
Memantine – weaker NMDA receptor antagonist, used in treating Alzheimer’s Disease
Cholinergic neurochemistry
Acetylcholine (Ach) is made from acetyl-CoA + choline by choline acyl transferase (ChAT) in presynaptic terminals
Ach is packed into vesicles by vesicular Ach transferase (vACht)
Acetylcholine is broken down in the synaptic cleft by acetylcholinesterase (ACE) to acetate + choline
Choline is taken back up by presynaptic terminal – recycle!
Nicotinic vs cholinergic receptors
Nicotinic AchRs are ionotropic (sodium, potassium, calcium), used for rapid transmission in the brain, autonomic ganglia, and NMJ – many subtypes
Muscarinic AchRs are metabotropic, widely used in autonomic target tissues (sweat glands pancreas, GI, salivary, lacrimal, pupils, etc.) and in the brain
Cholinergic toxicity
Insecticides bind and disrupt acetylchlinesterase->can’t break down Ach->weakness due to NMJ effects and also SLUDGE toxidrome
– Salivation
– Lacrimation
– Urination
– Diaphoresis
– GI upset
– Emesis
Atropine blocks muscarinic AChRs->blocks SLUDGE symptoms
Nerve gas (Sarin, VX) irreversibly bind acetylcholinesterase
Donepezil (Aricept)
Binds and reversibly inactivates the cholinesterases, thus inhibiting hydrolysis of acetylcholine. This increases acetylcholine concentrations at cholinergic synapses
Pyrdistigmine
Weakly blocks acetylcholinesterase, used to treat myasthenia gravis– excess causes SLUDGE